Tofacitinib in Moderate to Severe Ulcerative Colitis patients naive to biological therapy: A prospective real world analysis of efficacy and safety

被引：0
|
作者：
Banerjee, R. [1 ]
Dhanush, M. [1 ]
Raghunathan, N. [1 ]
Pal, P. [1 ]
Joshi, V. [1 ]
Patel, R. [1 ]
Godbole, S. [1 ]
Akki, Y. [1 ]
Valluri, S. [1 ]
Nagasuri, P. [1 ]
Haridas, A. [1 ]
机构：
[1] AIG Hosp, Inflammatory Bowel Dis, Hyderabad, India
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P706
引用
收藏
页码：I1323 / I1325
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of tofacitinib for the treatment of moderate- severe ulcerative colitis in biologic naive patients
    Liatsos, C.
    Michalopoulos, G.
    Tzouvala, M.
    Giouleme, O.
    Kozompoli, D.
    Mousourakis, K.
    Kyriakos, N.
    Giakoumis, M.
    Striki, A.
    Karoumpalis, I.
    Bellou, G.
    Zacharopoulou, E.
    Katsoula, A.
    Kalogirou, M.
    Viazis, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1718 - I1718
  • [2] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [3] EARLY 'REAL WORLD' EXPERIENCE WITH TOFACITINIB FOR MODERATE TO SEVERE ULCERATIVE COLITIS
    Honap, Sailish
    Sharma, Esha
    Ray, Shuvra
    Cunningham, Georgina
    Tamilarasan, Aravind
    Mawdsley, Joel
    Anderson, Simon
    Sanderson, Jeremy
    Irving, Peter
    [J]. GUT, 2019, 68 : A78 - A79
  • [4] Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian Real world
    Parra-Izquierdo, Viviana
    Frias-Ordonez, Juan Sebastian
    Cuadros, Carlos
    Vargas, Melquicedec
    Chamorro, Jose Fernando Vera
    Sanchez, Consuelo Romero
    Florez-Sarmiento, Cristian
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (06): : 574 - 581
  • [5] Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
    Xiao, Y.
    Lakatos, P. L.
    Bourdages, R.
    Bitton, A.
    Afif, W.
    Kohen, R.
    Berberi, M.
    Bessissow, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S445 - S445
  • [6] Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
    Natsuki Ishida
    Takahiro Miyazu
    Satoshi Tamura
    Shinya Tani
    Mihoko Yamade
    Moriya Iwaizumi
    Yasushi Hamaya
    Satoshi Osawa
    Takahisa Furuta
    Ken Sugimoto
    [J]. Digestive Diseases and Sciences, 2022, 67 : 3984 - 3992
  • [7] Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
    Ishida, Natsuki
    Miyazu, Takahiro
    Tamura, Satoshi
    Tani, Shinya
    Yamade, Mihoko
    Iwaizumi, Moriya
    Hamaya, Yasushi
    Osawa, Satoshi
    Furuta, Takahisa
    Sugimoto, Ken
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 3984 - 3992
  • [8] Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis
    Ng, Alexander Clevewood
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 (10): : 1774 - 1774
  • [9] Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience
    Parra-Izquierdo, Viviana
    Frias-Ordonez, Juan Sebastian
    Marquez, Juan Ricardo
    Juliao-Banos, Fabian
    Galindo, Pablo
    Cuadros, Carlos
    Rojas, Carlos
    Rojas, Nelson
    Ardila, Oscar
    Tovar-Fierro, German
    Garcia-Duperly, Rafael
    Vargas, Melquicedec
    Florez-Sarmiento, Cristian
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (07): : 512 - 521
  • [10] Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis
    Kojima, Kentaro
    Watanabe, Kenji
    Kawai, Mikio
    Yagi, Soichi
    Kaku, Koji
    Ikenouchi, Maiko
    Sato, Toshiyuki
    Kamikozuru, Koji
    Yokoyama, Yoko
    Takagawa, Tetsuya
    Shimizu, Masahito
    Shinzaki, Shinichiro
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (13)
12345